These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35759355)

  • 21. Improving Dissolution Behavior and Oral Absorption of Drugs with pH-Dependent Solubility Using pH Modifiers: A Physiologically Realistic Mass Transport Analysis.
    Salehi N; Kuminek G; Al-Gousous J; Sperry DC; Greenwood DE; Waltz NM; Amidon GL; Ziff RM; Amidon GE
    Mol Pharm; 2021 Sep; 18(9):3326-3341. PubMed ID: 34428047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of the Gastrointestinal Simulator (GIS) Coupled with In Silico Modeling to Measure the Impact of Coca-Cola
    Hens B; Bermejo M; Cristofoletti R; Amidon GE; Amidon GL
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32570975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers.
    Noehr-Jensen L; Damkier P; Bidstrup TB; Pedersen RS; Nielsen F; Brosen K
    Eur J Clin Pharmacol; 2006 Jun; 62(6):437-45. PubMed ID: 16770647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GORD and Barrett's oesophagus after bariatric procedures: multicentre prospective study.
    Genco A; Castagneto-Gissey L; Gualtieri L; Lucchese M; Leuratti L; Soricelli E; Casella G
    Br J Surg; 2021 Dec; 108(12):1498-1505. PubMed ID: 34738106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving mechanical properties of desloratadine via multicomponent crystal formation.
    Ainurofiq A; Mauludin R; Mudhakir D; Umeda D; Soewandhi SN; Putra OD; Yonemochi E
    Eur J Pharm Sci; 2018 Jan; 111():65-72. PubMed ID: 28958892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Short-term Safety of One Anastomosis Gastric Bypass to Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in the United States: 341 cases from MBSAQIP-accredited Centers.
    Jung JJ; Park AK; Witkowski ER; Hutter MM
    Surg Obes Relat Dis; 2022 Mar; 18(3):326-334. PubMed ID: 34896012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.
    Kreutner W; Hey JA; Anthes J; Barnett A; Young S; Tozzi S
    Arzneimittelforschung; 2000 Apr; 50(4):345-52. PubMed ID: 10800633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Vitro, in Silico, and in Vivo Assessments of Intestinal Precipitation and Its Impact on Bioavailability of a BCS Class 2 Basic Compound.
    Kou D; Zhang C; Yiu H; Ng T; Lubach JW; Janson M; Mao C; Durk M; Chinn L; Winter H; Wigman L; Yehl P
    Mol Pharm; 2018 Apr; 15(4):1607-1617. PubMed ID: 29522347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years.
    Salmun LM; Herron JM; Banfield C; Padhi D; Lorber R; Affrime MB
    Clin Ther; 2000 May; 22(5):613-21. PubMed ID: 10868558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability.
    Berlin M; Przyklenk KH; Richtberg A; Baumann W; Dressman JB
    Eur J Pharm Biopharm; 2014 Nov; 88(3):795-806. PubMed ID: 25195981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physico-chemical characterization and in vitro/in vivo evaluation of loratadine:dimethyl-β-cyclodextrin inclusion complexes.
    Szabados-Nacsa A; Sipos P; Martinek T; Mándity I; Blazsó G; Balogh Á; Szabó-Révész P; Aigner Z
    J Pharm Biomed Anal; 2011 May; 55(2):294-300. PubMed ID: 21316895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Vivo Dissolution and Systemic Absorption of Immediate Release Ibuprofen in Human Gastrointestinal Tract under Fed and Fasted Conditions.
    Koenigsknecht MJ; Baker JR; Wen B; Frances A; Zhang H; Yu A; Zhao T; Tsume Y; Pai MP; Bleske BE; Zhang X; Lionberger R; Lee A; Amidon GL; Hasler WL; Sun D
    Mol Pharm; 2017 Dec; 14(12):4295-4304. PubMed ID: 28937221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A combined in vitro in-silico approach to predict the oral bioavailability of borderline BCS Class II/IV weak base albendazole and its main metabolite albendazole sulfoxide.
    Pettarin M; Bolger MB; Chronowska M; Kostewicz ES
    Eur J Pharm Sci; 2020 Dec; 155():105552. PubMed ID: 32937212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developing a High-performance Liquid Chromatography Method for Simultaneous Determination of Loratadine and its Metabolite Desloratadine in Human Plasma.
    Sebaiy MM; Ziedan NI
    Curr Drug Metab; 2019; 20(13):1053-1059. PubMed ID: 31774044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laparoscopic Conversion of Sleeve Gastrectomy to One Anastomosis Gastric Bypass in a Hostile Abdomen.
    Kapoulas S; Sahloul M; Singhal R
    Obes Surg; 2021 Jun; 31(6):2845-2846. PubMed ID: 33830445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbopol®-crospovidone interpolymer complex for pH-dependent desloratadine release.
    Szakonyi G; Zelkó R
    J Pharm Biomed Anal; 2016 May; 123():141-6. PubMed ID: 26897295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Robust analysis of the hydrophobic basic analytes loratadine and desloratadine in pharmaceutical preparations and biological fluids by sweeping-cyclodextrin-modified micellar electrokinetic chromatography.
    El-Awady M; Belal F; Pyell U
    J Chromatogr A; 2013 Sep; 1309():64-75. PubMed ID: 23953618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roux-en-Y gastric bypass versus one anastomosis-mini gastric bypass as a rescue procedure following failed restrictive bariatric surgery. A systematic review of literature with metanalysis.
    Velotti N; Vitiello A; Berardi G; Di Lauro K; Musella M
    Updates Surg; 2021 Apr; 73(2):639-647. PubMed ID: 33606148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circadian time-effect of orally administered loratadine on plasma pharmacokinetics in mice.
    Dridi D; Ben-Attia M; Sani M; Djebli N; Sauvage FL; Boughattas NA
    Chronobiol Int; 2008 Jul; 25(4):533-47. PubMed ID: 18622814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology and clinical efficacy of desloratadine as an anti-allergic and anti-inflammatory drug.
    Agrawal DK
    Expert Opin Investig Drugs; 2001 Mar; 10(3):547-60. PubMed ID: 11424898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.